导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -21.14% | 1005/1050 |
| 近一周 | -4.60% | 1043/1104 |
| 近一月 | -5.23% | 628/1102 |
| 近一季 | -6.79% | 509/1092 |
| 近半年 | -15.57% | 902/1070 |
| 近一年 | -30.39% | 990/1018 |
| 近两年 | 34.02% | 645/926 |
| 近三年 | 5.14% | 623/834 |
| 成立以来 | -0.49% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-10.87% 1017/1070 |
-10.01% 909/1101 |
- - |
- - |
| 2025 | 35.83% 381/1065 |
15.71% 48/1014 |
6.94% 197/1038 |
29.49% 364/1050 |
-15.23% 986/1065 |
| 2024 | 11.56% 253/1011 |
-10.80% 789/960 |
5.70% 79/983 |
17.66% 114/991 |
0.56% 290/1011 |
| 2023 | -23.12% 745/952 |
-3.31% 756/880 |
-9.02% 738/895 |
-6.04% 369/915 |
-6.99% 672/952 |
| 2022 | -9.16% 79/867 |
-12.70% 169/773 |
10.06% 265/806 |
-17.76% 701/845 |
14.96% 37/867 |
| 2021 | -17.70% 527/740 |
0.47% 133/580 |
3.00% 501/659 |
-15.17% 614/704 |
-6.25% 619/740 |
| 2020 | 13.30% 396/554 |
-9.78% 379/419 |
11.12% 391/466 |
-0.28% 423/517 |
13.34% 241/554 |
| 2019 | - - |
- - |
0.82% 252/1228 |
-3.90% 368/390 |
8.86% 201/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 汇丰晋信港股通精选股票 VS. 东吴新产业精选股票A(580008) |